GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Price-to-Funds-From-Operations

Alto Neuroscience (Alto Neuroscience) Price-to-Funds-From-Operations : (As of May. 26, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Alto Neuroscience (Alto Neuroscience) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.